Budesonide + Glycopyrronium Bromide + Formoterol Fumarate
Indications
The Budesonide + Glycopyrronium Bromide + Formoterol Fumarate inhaler is used as maintenance treatment for people with Chronic Obstructive Pulmonary Disease (COPD). It is not meant for relieving acute bronchospasm, so it won't work as a rescue inhaler during a sudden attack.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
This medicine combines three drugs: Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Dihydrate. Budesonide is a corticosteroid, and it reduces the swelling and irritation in the lungs. Formoterol and Glycopyrronium are long-acting bronchodilators. They work in different ways to relax the muscles in the airways, which opens the airways wider and makes breathing easier. This helps prevent symptoms such as wheezing, cough, chest tightness and shortness of breath.
Pregnancy & Breastfeeding
Pregnancy: There isn't enough data on the use of Budesonide, Formoterol and Glycopyrronium in pregnant women. Glucocorticoid agents are known to cause effects in the early phase of gestation, and beta-2 sympathomimetic agents such as Formoterol have tocolytic effects. So, as a precaution, it's preferable to avoid this combination during pregnancy and labour. It should be used in pregnancy only if the expected benefit to the patient outweighs the potential risk to the fetus. Infants and neonates born to mothers who received substantial doses should be observed for adrenal suppression.
Lactation: No adequate and well-controlled studies have looked at breastfed children or milk production with Budesonide, Formoterol and Glycopyrronium products, or with its three components, Budesonide, Formoterol Fumarate and Glycopyrronium.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.